Katie Price: Harvey's health battle with weight loss jab

Katie Price's eldest son, Harvey, is set to begin treatment with the weight loss drug Mounjaro. This decision follows his Body Mass Index (BMI) reaching a level indicative of morbid obesity, reportedly at 59. Price emphasized that this intervention is for Harvey's health and not for cosmetic reasons, hoping it will enhance his quality of life.

The medication aims to improve Harvey's mobility, energy levels, and reduce the physical strain he experiences. Currently, Harvey struggles with walking, often becoming breathless and sweating, which has led medical professionals to warn of his high risk of a heart attack.

Harvey, aged 24, lives with his mother after moving out of his residential home. He has been diagnosed with Prader-Willi syndrome, a genetic condition, and also faces challenges including autism and blindness due to septa-optic dysplasia. His weight is a significant concern, with his mother mentioning he is just under 30 stone.

Separately, Price discussed Harvey's relationship with his birth father, Dwight Yorke. She noted that Yorke has had minimal contact with his son throughout his life, estimating only six visits. Despite ongoing efforts by Price's mother to foster a connection, Yorke has reportedly shown no interest in being involved in Harvey's life.